In silico designed small molecule targets misfolded TDP-43 to rescue function and ALS pathology

The DNA/RNA binding protein TARDBP or TDP-43 is a key driver of pathology in Amyotrophic Lateral Sclerosis (ALS), a motor neuron disease with no known cure. In >97% of sporadic ALS patients, nuclear TDP-43 in motor neurons mislocalizes and aggregates in the cellular cytoplasm (gain-of-function). A parallel reduction in nuclear TDP-43 in ALS patients leads to a loss-of-function in mRNA binding and splicing regulation. Using our machine learning platform, we discovered ACE-339, a novel, orally bioavailable small molecule that disrupts insoluble TDP-43 aggregates. Using in vitro, in vivo and in silico models, we show that ACE-339 directly targets aggregated forms of TDP-43. ACE-339 interacts directly with TDP-43 hexamers, disaggregates recombinant TDP-43 and rescues both gain- and loss-of-function phenotypes of TDP-43 in cells. ACE-339 functionally rescues TDP-43 dependent mis-splicing and synaptic activity. Lastly, ACE-339 rescues disease associated phenotypes in two independent mouse models of TDP-43 pathology. In addition, we now have a catalog of TDP-43 disaggregating compounds that are being developed further to be tested in clinical trials in patients with ALS and other TDP-43 proteinopathies.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.14.766688
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

In silico designed small molecule targets misfolded TDP-43 to rescue function and ALS pathology

Vidhu Mathur, Pritam Ganguly, Naomi Moreno, Rakez Kayed et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Amyotrophic Lateral Sclerosis Research
preprint

In silico designed small molecule targets misfolded TDP-43 to rescue function and ALS pathology

Vidhu Mathur, Pritam Ganguly, Naomi Moreno, Rakez Kayed, Miheer Sabale, Md. Anzarul Haque, Yazi Diana Ke, Joan–Emma Shea, Lewis Whitehead, Shruti Arya, Marcela Kokes, Annika van Hummel, Agenor Limón, Devi Supriya Korumilli, Eric Shao, Vanessa Seawright, Ambuj Singh, Catherine Planey
preprint en

Abstract

The DNA/RNA binding protein TARDBP or TDP-43 is a key driver of pathology in Amyotrophic Lateral Sclerosis (ALS), a motor neuron disease with no known cure. In >97% of sporadic ALS patients, nuclear TDP-43 in motor neurons mislocalizes and aggregates in the cellular cytoplasm (gain-of-function). A parallel reduction in nuclear TDP-43 in ALS patients leads to a loss-of-function in mRNA binding and splicing regulation. Using our machine learning platform, we discovered ACE-339, a novel, orally bioavailable small molecule that disrupts insoluble TDP-43 aggregates. Using in vitro, in vivo and in silico models, we show that ACE-339 directly targets aggregated forms of TDP-43. ACE-339 interacts directly with TDP-43 hexamers, disaggregates recombinant TDP-43 and rescues both gain- and loss-of-function phenotypes of TDP-43 in cells. ACE-339 functionally rescues TDP-43 dependent mis-splicing and synaptic activity. Lastly, ACE-339 rescues disease associated phenotypes in two independent mouse models of TDP-43 pathology. In addition, we now have a catalog of TDP-43 disaggregating compounds that are being developed further to be tested in clinical trials in patients with ALS and other TDP-43 proteinopathies.

bioRxiv (Cold Spring Harbor Laboratory)
University of California, Santa Barbara (US), Acelot (United States) (US), The University of Texas Medical Branch at Galveston (US), Macquarie University (AU)
Georgetown University, Target ALS, Macquarie University, University of California, Irvine
Good health and well-being
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon